INSIGHTS ON CLINICAL TRIAL PARTNERING
-
The Rescue Option: Course Correcting Struggling Clinical Trials
The willingness to seek expert support from Rescue CROs when clinical trials face critical challenges is not a sign of weakness but a demonstration of accountability and commitment to excellence.
-
Innovative FSP Solutions For Biopharma Growth And Transition
To optimize clinical development, the pharmaceutical industry is increasingly adopting innovative outsourcing strategies with CROs.
-
The Scout Portal Helps Sites Hit SCRS'25 In 25 Goal
Reducing site training time starts with intuitive tools. Aligning with SCRS’s 25 in 25 goal means eliminating complexity and empowering staff to focus on trial execution.
-
The Path Forward In Oncology Trials
A comprehensive site support model is crucial for navigating the complexities of modern oncology trials and accelerating drug development.
-
Clinical Trial Payments And Ethics: Your Top Questions Answered5/22/2025
Fair compensation in trials requires distinguishing reimbursement from stipends. Learn the ethical principles that ensure payments uphold participant respect and remove financial barriers.
-
Empowering Mid-Size Pharma Companies With Integrated Drug Development, Regulatory Strategy, And AI Innovation10/23/2025
A consultative, tech-enabled CRO can help mid-size pharma achieve targets by supplementing skillsets, expanding global reach, and designing an effective clinical, regulatory, and operational strategy.
-
Ergomed's Solutions To The Challenges of Oncology Trials4/15/2025
Explore a pivotal Phase III global clinical trial investigating neoadjuvant immunotherapy for locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).
-
Autoinjectors: A Revolutionary Leap In Drug Delivery2/7/2024
Explore how the widespread adoption of autoinjectors is transforming the biopharmaceutical industry's approach to drug delivery, offering precise dosing, patient adherence, and safety.
-
Why Bioanalysis Needs To Break Free From Manual Bottlenecks9/2/2025
Bioanalysis remains one of the most persistent bottlenecks in drug development, with CROs displaying inefficiencies that are no longer operational nuisances but strategic liabilities.
CLINICAL TRIAL PARTNERING SOLUTIONS
-
Our experienced Regional Site Managers (RSMs) are recapturing the importance of building relationships with clinical sites. Our RSMs can act as a “one-stop shop” for all activities related to a clinical study site.
-
The BEC 300, manufactured by Uhlmann, is the eighth blister line at Ropack Pharma Solutions. The single-lane unit integrates blistering, cartoning, and serialization.
-
Generate accurate study budgets faster with the industry’s most contemporary fair market value (FMV) data for investigator grant costs based on real-world site costs.
-
Many biotechnology companies come to Australia to conduct early phase clinical trials and take advantage of straightforward regulatory streams and of the lucrative 43.5% R&D cash refund scheme. Biotechnology companies then often look at locations in Asia, such as South Korea, Thailand and China to tap into their huge treatment-naïve patient populations for their later phase clinical research.
-
Dual sourcing should be implemented to reduce risk and ensure an uninterrupted supply of critical, life-saving therapies. Recent FDA draft guidelines recommend risk management plans to prevent drug product shortages.